Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model-Reference-Cited by-同舟云学术

Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse Model

Published:2016-01 Issue:1 Volume:22 Page:64-73
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Lu Chi-Chen,Shen Cheng-Huang,Chang Chia-Bin,Hsieh Hsiao-Yen,Wu Jiann-Der,Tseng Ling-Huei,Hwang Dennis W,Chen Syue-Yi,Wu Shu-Fen,Chan Michael W Y,Hsu Cheng-Da

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2015.00085.pdf

Reference45 articles.

1. Roupret M, et al. (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur. Urol. 59:584–94.

2. Shen CH, et al. (2010) Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model. Br. J. Pharmacol. 160:2008–27.

3. Jacobs BL, Lee CT, Montie JE. (2010) Bladder cancer in 2010: how far have we come? CA Cancer J. Clin. 60:244–72.

4. Damrauer JS, et al. (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl. Acad. Sci. U. S. A. 111:3110–5.

5. Herr HW. (1997) Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients. World J. Urol. 15:84–8.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications;Journal of Ethnopharmacology;2024-01

2. Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia;Climacteric;2023-08-14

3. Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses;Frontiers in Oncology;2023-01-16

4. Integrating network pharmacology and transcriptomic validation to investigate the efficacy and mechanism of Mufangji decoction preventing lung cancer;Journal of Ethnopharmacology;2022-11

5. Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis;Taiwanese Journal of Obstetrics and Gynecology;2022-01